中文
|
English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Home
About Journal
Journal Introduction
Editorial Board
Reviewers
Style of Editorial Department
Advertising Policies
Submission Guideline
Instructions for Authors
Editorial Policies
Open Access Policy
Publishing Ethics
Publication Process Flow
Peer Review Process
Conflict of interest statement
Statement of Human and Animal Rights
Statement of Informed Consent and ethical approval
Data Sharing Policy
Statement of Copyright information
Open Science Identifier (OSID) Recording
Paper Template
Handling method for withdrawal
Journal Online
Online First
Current Issue
Archive
F5000 Articles
Hepatobiliary College
Guide to foreign journals
Industry information
Video Classroom
Guidelines
All Guidelines
Domestic guidelines
Foreign guidelines
Guideline translation
Guideline interpretation
Menu
All
Title
Author
Keyword
Abstract
DOI
Category
Address
Fund
Home
About Journal
Journal Introduction
Editorial Board
Reviewers
Style of Editorial Department
Advertising Policies
Submission Guideline
Instructions for Authors
Editorial Policies
Open Access Policy
Publishing Ethics
Publication Process Flow
Peer Review Process
Conflict of interest statement
Statement of Human and Animal Rights
Statement of Informed Consent and ethical approval
Data Sharing Policy
Statement of Copyright information
Open Science Identifier (OSID) Recording
Paper Template
Handling method for withdrawal
Journal Online
Online First
Current Issue
Archive
F5000 Articles
Hepatobiliary College
Guide to foreign journals
Industry information
Video Classroom
Guidelines
All Guidelines
Domestic guidelines
Foreign guidelines
Guideline translation
Guideline interpretation
PDF
Cite
Share
facebook
twitter
google
linkedin
All
Title
Author
Keyword
Abstract
DOI
Category
Address
Fund
Volume 40
Issue 5
May 2024
Turn off MathJax
Article Contents
References
Article Navigation
>
Journal of Clinical Hepatology
>
2024
>
40(5): 1002-1002
PDF
( 892 KB)
Hepatology Communications
|Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis
DOI:
10.12449/JCH2405.gwqkjpwzjj3
Published Date:
2024-05-25
Abstract
FullText(HTML)
References
(0)
References
Relative Articles
Relative Articles
[1]
Journal of Hepatology
|Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes
[J]. Journal of Clinical Hepatology, 2024, 40(2): 257-257.
doi:
10.12449/JCH2402.gwqkjpwzjj1
[2]
Xueyun GUO, Xuan ZHONG, Tingting ZHANG, Sihai CHEN, Wang ZHANG, Bimin LI, Xuan ZHU, Anjiang WANG.
Risk factors for death within 30 days after admission in patients with decompensated liver cirrhosis and acute kidney injury and construction of a nomogram model
[J]. Journal of Clinical Hepatology, 2024, 40(11): 2221-2228.
doi:
10.12449/JCH241115
[3]
Journal of Hepatology
|Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy
[J]. Journal of Clinical Hepatology, 2024, 40(11): 2237-2237.
doi:
10.12449/JCH2411.gwqkjpwzjj2
[4]
Journal of Hepatology
|Development and validation of a prognostic model for 90-day survival in patients with alcohol-associated cirrhosis and acute decompensation
[J]. Journal of Clinical Hepatology, 2024, 40(3): 520-520.
doi:
10.12449/JCH2403.gwqkjpwzjj2
[5]
Hepatology International
|Incidence, risk factors, and outcomes of acute liver injury in hospitalized adults with acute kidney injury: a large multicenter study
[J]. Journal of Clinical Hepatology, 2024, 40(6): 1182-1182.
doi:
10.12449/JCH2406.gwqkjpwzjj1
[6]
Hepatology Communications
|Efficient silencing of hepatitis B virus S gene through CRISPR-mediated base editing
[J]. Journal of Clinical Hepatology, 2022, 38(6): 1369-1369.
doi:
10.3969/j.issn.1001-5256.2022.06.gwjpwzjj2
[7]
Journal of Hepatology
|Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acutely decompensated cirrhosis
[J]. Journal of Clinical Hepatology, 2022, 38(12): 2876-2876.
doi:
10.3969/j.issn.1001-5256.2022.12.gwjpwzjj3
[8]
Journal of Hepatology
|Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis
[J]. Journal of Clinical Hepatology, 2022, 38(12): 2766-2766.
doi:
10.3969/j.issn.1001-5256.2022.12.gwjpwzjj2
[9]
Yuhao YAO, Xiao XIA, Jiaxin ZHANG, Xiaoke LI, Yong'an YE.
Application of proton pump inhibitors in acute-on-chronic liver failure
[J]. Journal of Clinical Hepatology, 2022, 38(12): 2864-2867.
doi:
10.3969/j.issn.1001-5256.2022.12.035
[10]
Shanshan LI, Manman XU, Zhongping DUAN, Yu CHEN.
Risk factors for liver cirrhosis in acute-on-chronic liver failure patients without liver cirrhosis in the convalescence stage
[J]. Journal of Clinical Hepatology, 2021, 37(12): 2824-2829.
doi:
10.3969/j.issn.1001-5256.2021.12.019
[12]
P YO JH, K IM TJ, L EE H, HAO MiaoMiao, GAO PuJun.
Proton pump inhibitors use and the risk of fatty liver disease:A nationwide cohort study
[J]. Journal of Clinical Hepatology, 2020, 36(11): 2504-2504.
[13]
LIU LinXiang, NIE Yuan, ZHU Xuan.
Research advances in proton pump inhibitor and complications of liver cirrhosis
[J]. Journal of Clinical Hepatology, 2020, 36(11): 2557-2560.
doi:
10.3969/j.issn.1001-5256.2020.11.036
[17]
Wu Jian, Yin Fang, Luo GuanHong, Zhu ShaoHua, Li Hong, Zhang Jing, Zheng YangYang, Sun Han, Zhou XinMin.
Association of hyponatremia with degree of liver injury and complications in patients with decompensated liver cirrhosis
[J]. Journal of Clinical Hepatology, 2017, 33(2): 277-280.
doi:
10.3969/j.issn.1001-5256.2017.02.014
Supplements
(0)
Cited By
Proportional views
Proportional views
Catalog
通讯作者:
陈斌, bchen63@163.com
1.
沈阳化工大学材料科学与工程学院 沈阳 110142
本站搜索
百度学术搜索
万方数据库搜索
CNKI搜索
Get Citation
PDF
XML
Article Metrics
Article views (
284
)
PDF downloads(
30
)
Cited by(
)
Proportional views
Related
Previous
Next
×
Close
Export File
Citation
Hepatology Communications|Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis[J]. J Clin Hepatol, 2024, 40(5): 1002-1002. DOI: 10.12449/JCH2405.gwqkjpwzjj3.
Hepatology Communications
|Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis[J].
J Clin Hepatol
, 2024, 40(5): 1002-1002.
DOI:
10.12449/JCH2405.gwqkjpwzjj3.
Format
RIS(for EndNote,Reference Manager,ProCite)
BibTex
Txt
Content
Citation Only
Citation and Abstract
/
DownLoad:
Full-Size Img
PowerPoint
Return
Return